Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Choose an application
Benzodiazepines --- Chemists --- Diazepam --- History. --- Sternbach, L. H.
Choose an application
Diazepam. --- Haloperidol. --- Mk-801. --- Rat. --- Rats. --- Stereotypies. --- Stereotypy.
Choose an application
Cortex. --- Diazepam. --- Dopamine. --- Increase. --- Microdialysis. --- Novelty. --- Pain. --- Prefrontal cortex. --- Release. --- Stress.
Choose an application
Several confounding factors may influence the outcome of an experiment and the extent of inter-individual variation. The aim of this study was to investigate if cage enrichment induces an effect on experimental mean values and on inter-individual variation in the light/dark paradigm using diazepam as the anxiolytic drug. The behaviour of 216 naive adult male mice of two different strains (BALB/c and C57BL/6) was studied. The animals were housed in groups of four in 'non-enriched', 'enriched' (nesting material) or 'super-enriched' (nest-box, nesting material, wooden gnawing stick and PVC tube) cages. After 5 weeks the animals were assigned to one of three treatments: control (no injection), sham (saline injection i.p.) or diazepam (1 mg/kg bw i.p.) and tested in the light/dark test for 5 min. Variation data were analysed using three different methods (mean absolute deviation, coefficient of variation and power analysis). The C57BL/6 mice scored higher than BALB/c mice in activity related measurements and showed a less 'emotional' behaviour profile in the pharmacological control situation of the light/dark test. In this study the anxiolytic effect of diazepam was clear in BALB/c mice but absent in C57BL/6 mice. Mice housed in enriched and super-enriched cages gained more weight than mice in non-enriched cages, although food intake was not affected. Generally, the strain of mouse had the greatest impact on both mean values and variation. However, there was no consistent increase for one particular strain. The choice of statistical method for analysing variation may influence the interpretation of within-group variability, but none of the methods showed any significant differences between standard and enriched conditions on variability in any of the parameters measured
Activity. --- Adult. --- Analysis. --- Animal-models. --- Animal. --- Animals. --- Anxiety. --- Behavior. --- Behaviour. --- Cage. --- Choice. --- Control. --- Diazepam. --- Drug. --- Enriched. --- Enrichment. --- Environmental enrichment. --- Experiment. --- Food intake. --- Food. --- Group. --- Housing,exploration,activity,emotionality,laboras,mice. --- Inbred strains. --- Increase. --- Laboratory mice. --- Light/dark test. --- Male-mice. --- Male. --- Method. --- Mice. --- Mouse. --- Nest box. --- Nesting material. --- Parameters. --- Preferences. --- Pvc. --- Rats. --- Test. --- Treatment. --- Validation. --- Variability. --- Variation. --- Weight.
Choose an application
Rats undergoing extinction of lever-pressing for food after session not preceded by signal attenuation, paroxetine, the attenuation of an external feedback for this behavior, fluvoxamine and desipramine affected only the number of exhibit excessive lever-pressing unaccompanied by an attempt to collect a reward, which may be analogous to the excessive and unreasonable behavior seen in obsessive-compulsive disorder (OCD). Given that one of the most salient features of OCD is its selective response to treatment with serotonin re-uptake inhibitors (SRIs), the present study compared the effects of the SRIs paroxetine and fluvoxamine on compulsive lever-pressing, with those of the tricyclic antidepressant, desipramine, and the benzodiazepine, diazepam, which are not effective in the treatment of OCD. Paroxetine (11-15 mg/kg) and fluvoxamine (10-20 mg/kg) dose-dependently reduced the number of compulsive lever-presses and the number of lever-presses followed by an attempt to collect a reward; desipramine (5-15 mg/kg) dose-dependently reduced only the number of lever-presses followed by an attempt to collect a reward; diazepam (2-10 mg/kg) did not affect either type of lever-pressing, except for the highest dose (110 mg/kg), which almost completely abolished lever-press responding. When administered in an extinction lever-presses followed by an attempt to collect a reward, whereas diazepam (4-8 mg/kg) decreased both types of lever-presses. The present findings strengthen the suggestion that compulsive lever-pressing may serve to model compulsive behavior in OCD, and lends the model predictive validity
Animal model. --- Animal-model. --- Antidepressant. --- Anxiety. --- Anxiolytic. --- Behavior. --- Benzodiazepine. --- Benzodiazepines. --- Compulsive. --- Diazepam. --- Disorder. --- Drug-treatment. --- Extinction. --- Feedback. --- Food. --- Lever-press. --- Model. --- Obsessive-compulsive disorder. --- Obsessive-compulsive. --- Ocd (obsessive-compulsive disorder). --- Ocd. --- Pharmacotherapy. --- Post-training signal attenuation. --- Rat. --- Rats. --- Response. --- Reward. --- Schizophrenia. --- Serotonin. --- Time. --- Training signal attenuation. --- Treatment.
Choose an application
Recent clinical evidence supports the potential of neurokinin NK1 receptor antagonists as novel antidepressant drugs. A number of NK1 antagonists have reduced affinity for rat and mouse NK1 receptors compared to human, making it difficult to test for efficacy in traditional animal models. NK1 antagonists, in general, have similar affinity at gerbil and human NK1 receptors. The aims of these studies were, first to validate the gerbil tail suspension test, a test used frequently to demonstrate antidepressant drug efficacy in mice, and second, to determine whether the test could be used to demonstrate the antidepressant potential of NK1 antagonists. Immobility time was reduced by oral administration of the antidepressants imipramine (3-30 mg/kg), desipramine (1-30 mg/kg), amitriptyline (30 mg/kg), fluoxetine (1-30 mg/kg), paroxetine (3-10 mg/kg), citalopram (0.1-3 mg/kg), sertraline (1-30 mg/kg), venlafaxine (1-30 mg/kg) and nefazodone (100 mg/kg). Furthermore, oral administration of the NK1 antagonists M K-869 (10 mg/kg), L-742,694 (110 mg/kg), L-733,060 (10 mg/kg), CP-99,994 (30 mg/kg), and CP-122,721 (3-30 mg/kg) reduced immobility time. Diazepam (1-10 mg/kg), chlordiazepoxide (1-10 mg/kg), buspirone (3-30 mgAg), FG-7142 (1-30 mg/kg), and haloperidol (1-10 mg/kg) did not reduce immobility. Amphetamine (0.3-10 mg/kg) and atropine (0.3-10 mg/kg) reduced immobility, suggesting susceptibility to false positives, e.g. compounds that affect locomotion. Compounds were therefore tested in a gerbil locomotor activity (LMA) test to ensure that the antidepressant-like effects were not secondary to effects on activity. Antidepressant drugs and NK1 antagonists had no effect on LMA at doses that reduced immobility, whereas amphetamine and atropine induced marked hyperactivity. These studies support both the utility of gerbils in behavioral pharmacology and the antidepressant potential of selective NK1 antagonists
Activity. --- Amphetamine. --- Animal model. --- Animal-model. --- Animal-models. --- Animal. --- Antidepressant drugs. --- Antidepressant. --- Anxiolytic-like. --- Atropine. --- Behavior. --- Blockade. --- Citalopram. --- Depression. --- Diazepam. --- Drug. --- Drugs. --- Fluoxetine. --- Gerbil. --- Gerbils. --- Haloperidol. --- Human. --- Hyperactivity. --- Immobility. --- Inhibition. --- Locomotion. --- Locomotor activity. --- Locomotor-activity. --- Mice. --- Model. --- Models. --- Mouse. --- Neurokinin nk1 receptor antagonists. --- Neurokinin nk1 receptor. --- Nk1 receptor antagonists. --- Nonpeptide antagonist. --- Pharmacology. --- Rat. --- Receptor antagonist. --- Receptor. --- Receptors. --- Social-interaction. --- Substance p. --- Substance-p receptors. --- Susceptibility. --- Tail suspension test. --- Test. --- Time.
Choose an application
Several neurokinin NK1 receptor antagonists currently being developed for anxiety and depression have reduced affinity for the rat and mouse NK1 receptor compared with human. Consequently, it has proven difficult to test these agents in traditional rat and mouse models of anxiety and depression. This issue has been overcome, in part, by using non-traditional lab species such as the guinea pig and gerbil, which have NK1 receptors closer in homology to human NK1 receptors. However, there are very few reports describing the behavior of gerbils in traditional models of anxiety. The aim of the present study was to determine if the elevated plus-maze, a commonly used anxiety model, could be adapted for the gerbil. Using a specially-designed elevated plus-maze, gerbils exhibited an 'anxious' behavioral profile similar to that observed in rats and mice, i.e., reduced entries into, and time spent exploring, an open, aversive arm. The anxiolytic drugs diazepam (0.03-3 mg/kg i.p.), chlordiazepoxide (0.3-10 mg/kg i.p.), and buspirone (0.3-30 mg/kg s.c.) increased open arm exploration and produced anxiolytic-like effects on risk-assessment behaviors (reduced stretch-attend postures and increased head dips). Of particular interest, the antidepressant drugs imipramine (1-30 mg/kg p.o.),fluoxetine (1-30 mg/kg, p.o.) and paroxetine (0.3-10 mg/kg p.o.) each produced some acute anxiolytic-like activity, without affecting locomotor activity. The antipsychotic, haloperidol, and the psychostimulant, amphetamine, did not produce any anxiolytic-like effects (1-10 mg/kg s.c). The anxiogenic beta-carboline, FG-7142, reduced time spent in the open arm and head dips, and increased stretch-attend postures (1-30 mg/kg, i.p.). These studies have demonstrated that gerbils exhibit an anxiety-like profile on an elevated plus-maze, and that the gerbil elevated plus-maze may have predictive validity for anxiolytics, and antidepressants with potential anxiolytic-like effects. (C) 2002 American Colle
5-ht1a agonist. --- Activity. --- Amphetamine. --- Antidepressant drugs. --- Antidepressant. --- Anxiety. --- Anxiolytic action. --- Anxiolytic drugs. --- Anxiolytic-like. --- Behavior. --- Benzodiazepines. --- Depression. --- Diazepam. --- Drug. --- Drugs. --- Elevated plus maze. --- Elevated plus-maze. --- Ethopharmacological analysis. --- Exploration. --- Fear. --- Gerbil. --- Gerbils. --- Guinea pig. --- Guinea-pig. --- Haloperidol. --- Human. --- Locomotor activity. --- Locomotor-activity. --- Mice. --- Model. --- Models. --- Mongolian gerbil. --- Mouse. --- Neurokinin nk1 receptor antagonists. --- Neurokinin nk1 receptor. --- Nk1 receptor antagonists. --- Pig. --- Posture. --- Rat. --- Rats. --- Receptor antagonist. --- Receptor. --- Receptors. --- Social-interaction test. --- Species-differences. --- Substance-p receptors. --- Tachykinin nk1 receptor. --- Test. --- Time. --- Validation.
Listing 1 - 9 of 9 |
Sort by
|